Overall rank by patents
#11,562
of 50,000 tracked assignees
USPTO PatentsView assignee record - 26 granted patents across 12 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
According to USPTO PatentsView, Axcella ranks #11,562 of 50,000 tracked US assignees by granted-patent volume, with 26 patents across 12 technology areas.
Axcella Health Inc. has been granted 26 US utility patents between 2017 and 2023, placing Axcella Health Inc. at #11,562 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Axcella Health Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Axcella sits between Australian Nuclear Science AND Technology Organisation (26 patents, rank #11,541) and Alfred Kaercher SE & Co. KG (26 patents, rank #11,549) - the closest US assignees by grant volume. The composite Innovation Score of 41.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 15 grants, compared with 11 in the 2015–2019 window, a +36% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Axcella Health Inc.'s 21.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
26 patents
AUTEFA SOLUTIONS GERMANY GMBH
26 patents
AUTOMOTIVE LIGHTING ITALIA S.p.A.
26 patents
AVerMedia TECHNOLOGIES, INC.
26 patents
Aero Industries, Inc.
26 patents
Agri-Cover, Inc.
26 patents
Aker Subsea AS
26 patents
Alfred Kaercher SE & Co. KG
26 patents
AXCELLA HEALTH INC.
26 patents
What this shows Axcella holds 26 patents at rank #11,545, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,545 in granted patent volume.
Other assignees with the most granted patents in Axcella's primary technology class.
Axcella's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 4 | 15.4% |
| 2018 | 2 | 7.7% |
| 2019 | 5 | 19.2% |
| 2020 | 3 | 11.5% |
| 2021 | 4 | 15.4% |
| 2022 | 2 | 7.7% |
| 2023 | 6 | 23.1% |
Top 12 of 12 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#11,562
of 50,000 tracked assignees
41.0 out of 100
How to use this portfolio
Axcella's 26 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.